Ignite Creation Date:
2024-05-06 @ 2:36 AM
Last Modification Date:
2024-10-26 @ 11:21 AM
Study NCT ID:
NCT02089828
Status:
UNKNOWN
Last Update Posted:
2016-04-19
First Post:
2014-03-14
Brief Title:
Purified CD34 Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Shanghai Zhongshan Hospital
Study Overview
Official Title:
Randomized Control Trial on Purified CD34 Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia
Status:
UNKNOWN
Status Verified Date:
2016-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To compare the efficacy and cost-effectiveness between purified CD34 cells and peripheral blood mononuclear cells in treatment of critical limb ischemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None